Safety of Day Case Percutaneous Liver Biopsies at a Tertiary Hospital in Nigeria.

Authors

Olusegun Adekanle, Olawumi Janet Kolawole, Oluwasegun Ijarotimi, Ibukunoluwa John Enesi, Dennis A Ndububa

Published in

The Nigerian postgraduate medical journal. Volume 33. Issue 5. Pages 561-566. Sep 01, 2026. Epub Aug 17, 2026.

Abstract

Percutaneous liver biopsy (PLB) is a procedure through which liver tissue is obtained for making the diagnosis of liver diseases. Most PLBs are performed as a day case procedure, and complications can occur.
This study assessed the safety of PLBs as a day case procedure.
A cross-sectional descriptive study of participants aged 18 years and above who had a day case PLB from January 2021 to June 2024. Standard precautions were observed, and eligible participants after the procedure were observed for 4-6 h. Post-biopsy complications were looked for and their time duration was recorded. Data obtained were collated and entered into SPSS version 20 and analysed using simple and inferential statistics. A P < 0.05 was considered statistically significant.
There were 125 participants comprising 71 (56.8%) females and 54 (43.2%) males, with an age range of 18-70 years, with a mean ± standard deviation (SD) of 44.4 (13.0) years. A total of 161 complications amongst 101 (80.8%) participants occurred, with some participants having two or more complications. The most common were pain at the shoulder tip, 41 (32.8%) and pain at the biopsy site, 93 (74.5%), with mean ± (SD) time duration of 58.9 (47.3) and 96.6 (71.7) min, respectively. Participants with metabolic dysfunction-associated steatotic liver disease, those aged > 40 years and participants with echogenic liver on ultrasound had more post-biopsy complications than others, P < 0.05. There was no death or post-biopsy admission.
Day case PLB is safe, and the most common complications are pain at the shoulder tip and biopsy site.

PMID:
42616967
Bibliographic data and abstract were imported from PubMed on 20 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.